The RNA Targeted Therapeutics industry has witnessed rapid innovation and increasing adoption across various clinical applications, positioning itself as a disruptive force in precision medicine. Boasting robust pipeline advancements and regulatory approvals throughout 2024 and 2025, this sector continues to demonstrate exceptional momentum in therapeutic solutions targeting previously...